Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Skye Bioscience Inc (SKYE)

Skye Bioscience Inc (SKYE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Skye Bioscience Inc 11250 EL CAMINO REAL SUITE 100 SAN DIEGO CA 92130 USA

www.skyebioscience.com Employees: 12 P: 858-410-0266

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Skye Bioscience Inc. is a biopharmaceutical company. It is focused on developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with significant unmet need. Skye Bioscience Inc., formerly known as Emerald Bioscience Inc., is based in San Diego, Calif.

Key Statistics

Overview:

Market Capitalization, $K 23,846
Enterprise Value, $K 17,966
Shares Outstanding, K 33,379
Float, K 32,378
% Float 97.00%
Short Interest, K 1,573
Short Float 4.71%
Days to Cover 1.00
Short Volume Ratio 0.42
% of Insider Shareholders 3.00%
% of Institutional Shareholders 21.09%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -55,920 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -14,440 K
EBIT, $ -58,160 K
EBITDA, $ -57,440 K

Growth:

1-Year Return -49.21%
3-Year Return -82.58%
5-Year Return -97.62%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 81.20%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.36 on 03/10/26
Next Earnings Date 05/14/26
Earnings Per Share ttm -1.40
EPS Growth vs. Prev Qtr -12.50%
EPS Growth vs. Prev Year -50.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-250 on 09/08/23

SKYE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -143.59%
Return-on-Assets % -119.89%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.12
Book Value/Share 0.62
Interest Coverage -2.54
60-Month Beta 2.87
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.